첫 페이지 News 본문

In this week's US stock market, a stock called Summit Pharmaceuticals (SMMT) emerged as a rising force. In addition to its own 160% surge, it also pulled up biotech companies such as BioNTech and Instil Bio. Since the beginning of the year, Summit Pharmaceuticals has risen from less than $3 to $31.93 at the end of this week, with a staggering increase of 1123.37%, and its market value has risen to $23.1 billion. Behind this, in addition to the common benefits of new drug development, there is also a story of China US cooperation.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
您需要登录后才可以回帖 登录 | Sign Up

本版积分规则

藏獒47 新手上路
  • Follow

    0

  • Following

    0

  • Articles

    3